Transactions
Supernus Pharmaceuticals, Inc.’s acquisition of Sage Therapeutics, Inc.
Date Announced:
06/16/2025
client:
Supernus Pharmaceuticals, Inc.
Status:
Pending
Value:
Up to $795 million
Centuri Holdings, Inc.’s secondary follow-on offering
Date Announced:
06/16/2025
client:
Centuri Holdings, Inc.
Status:
Closed – 06/18/2025
Value:
$255 million
MPE Partners’ acquisition of Renold plc
Date Announced:
06/13/2025
client:
MPE Mgt. Co. LLC (D.B.A. MPE Partners)
Status:
Pending
Value:
£187 million
Archer Aviation Inc.’s registered direct offering of common stock
Date Announced:
06/13/2025
client:
Archer Aviation Inc.
Status:
Closed – 06/16/2025
Value:
$850 million
Advantage Capital Holdings LLC’s divestment of Standard de Liège SA and Immobilière du Standard de Liège SRL
Date Announced:
06/06/2025
client:
Advantage Capital Holdings LLC
Status:
Closed – 06/06/2025
Value:
Undisclosed
TPG Rise Climate’s majority acquisition of Aurora Energy Research Ltd.
Date Announced:
06/04/2025
client:
TPG Rise Climate
Status:
Pending
Value:
Undisclosed
Viper Energy, Inc.’s acquisition of Sitio Royalties Corp.
Date Announced:
06/03/2025
client:
Viper Energy, Inc.
Status:
Pending
Value:
$4.1 billion
eProductivity Software, a portfolio company of STG Partners, LLC, acquisition of Avanti, a division of Ricoh Company, Ltd.
Date Announced:
06/02/2025
client:
EPS US, LLC (D.B.A. eProductivity Software)
Status:
Closed – 06/02/2025
Value:
Undisclosed
Acumatica, Inc., a portfolio company of EQT Partners, Inc., on its sale to Vista Equity Partners Management, LLC
Date Announced:
05/29/2025
client:
Acumatica, Inc.
Status:
Pending
Value:
Undisclosed
gategroup Holding AG’s refinancing transaction
Date Announced:
05/29/2025
client:
gategroup Holding AG
Status:
Closed – 06/17/2025
Value:
CHF 1.4 billion
Rhode sale to e.l.f. Beauty, Inc.
Date Announced:
05/28/2025
client:
HRBeauty LLC (DBA Rhode)
Status:
Pending
Value:
$1 billion
Khoros, LLC’s sale to IgniteTech
Date Announced:
05/27/2025
client:
Khoros, LLC
Status:
Closed – 05/27/2025
Value:
Undisclosed
HOOKIPA Pharma, Inc.’s asset sale to Gilead Sciences, Inc.
Date Announced:
05/22/2025
client:
HOOKIPA Pharma, Inc.
Status:
Pending
Value:
Undisclosed
Centuri Holdings, Inc.’s secondary follow-on offering
Date Announced:
05/20/2025
client:
Centuri Holdings, Inc.
Status:
Closed – 05/22/2025
Value:
$231 million